EN
HI
iSERA Lifesciences Chart
iSERA Lifesciences Share Key Metrics
Volume
9431.00
Market Cap
65.16 CR
LTQ@LTP
2000@77.49
ATP
77.49
Var Margin
100 %
Circuit Range
75.95-77.49
Delivery %
100 %
Value
7.31 L
ASM/GSM
No
Market Lot
1
Summary
iSERA Lifesciences share price stands at ₹77.49 at 4 May, 2026 | 13:15. The stock iSERA Lifesciences intraday movement has stayed between ₹77.49 and ₹77.49, while on a 52-week basis it has fluctuated from ₹1.50 to ₹77.49.
In terms of trading activity, iSERA Lifesciences has recorded a volume of 9431 shares. The iSERA Lifesciences has a market cap of ₹8408972. The stock’s Average Traded Price (ATP) stands at ₹7749, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 2000, 7749.
The iSERA Lifesciences operates within a circuit range of ₹75.95-77.49 – ₹75.95-77.49, with a Value of ₹7.31 L. The Delivery Percentage for the day is 100%. Additionally, iSERA Lifesciences currently falls under the No framework, and trades with a market lot size of 1.
iSERA Lifesciences Fundamentals
View MoreP/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
142.67
Sector P/B
3.08
Sec. Div. Yield
0.64
iSERA Lifesciences Resistance and Support
Pivot 77.49
Resistance
First Resistance
77.49
Second Resistance
77.49
Third Resistance
77.49
Support
First Support
77.49
Second Support
77.49
Third Support
77.49
iSERA Lifesciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-04-20 | Preferential issue of shares |
| 2026-02-10 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-10-09 | Rights issue of Equity Shares |
| 2025-10-03 | Rights issue of Equity Shares |
| 2025-08-01 | Quarterly Results |
| 2025-05-30 | Audited Results |
| 2025-02-10 | Quarterly Results |
iSERA Lifesciences News
Covidh Technologies Ltd - 534920 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
ISERA Lifesciences seeks shareholder approval for strategic moves, including increasing authorized capital to ₹25 crores and expanding investment limits to ₹1,000 crores. The company also plans to acquire iSERA Biological for ₹78 crores via a share swap to bolster its pharmaceutical and life sciences sector presence.
Apr 21 2026 18:04:00
Covidh Technologies Ltd - 534920 - Revised Outcome Of The Meeting Of The Board Of Directors Of Isera Lifesciences Limited (Formerly Known As Covidh Technologies Limited) ('The Company') Pursuant To Regulation 29 And 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
iSERA Lifesciences board approved the acquisition of 100% equity in iSERA Biological Limited for ₹78.00 crores, to be settled through a share swap. This move aims to expand its presence in pharmaceuticals and life sciences, creating synergistic value for shareholders.
Apr 21 2026 15:04:00
Read More
About iSERA Lifesciences
NSE : 0
BSE : 534920
ISIN : INE899M01020
The Company Fastrak Capitals Ltd. was originallyincorporated as private limited company under the name ofAarya Consultants (P) Ltd. on 27-1-93 and subsequentlychanged its name to Fastrak Capitals (P) Ltd. and obtainedcertificate of incorporation on 1-03-96 and subsequentlyconverted into Fastrak Capitals Limited and obtained freshcertificate of incorporation on 8-03-96 from the Registrarof Companies Andhra Pradesh Hyderabad. The Company hasstarted Commercial operations from 28-01-93. The Companyhas also been in the field of Project Consultancy andInvestment Consultancy. Being promoted by experiencedprofessional and armed with good professionals on theemployment rolls who have got good experience in thefinance and allied fields and further being equipped withgood information system and procedures and its own equityresearch division it was able to establish itself in theline of Investments Investment consultancy and ProjectConsultancy. The Company has developed wide contacts goodnetwork and poised to take-up other activities of MerchantBanking leasing and Hire-purchase.
iSERA Lifesciences Management
| Name | Position |
|---|---|
| Jayshree Suresh | Managing Director |
| Jitendra Prabhakar Nene | Executive Director |
iSERA Lifesciences Similar Stocks
Cranes Software International Ltd.
3.55
-0.08 (2.20%)
Riddhi Corporate Services Ltd.
57.50
-0.34 (0.59%)
HandsOn Global Management (HGM) Ltd.
56.60
2.62 (4.85%)
Cambridge Technology Enterprises Ltd.
34.39
0.89 (2.66%)
Jupiter Infomedia Ltd.
63.69
-0.17 (0.27%)
LCC Infotech Ltd.
4.69
-0.19 (3.89%)
Starcom Information Technology Ltd.
46.51
-1.65 (3.43%)
Suvidhaa Infoserve Ltd.
2.95
0.08 (2.79%)
iSERA Lifesciences FAQs
The Buying Price of iSERA Lifesciences share is 77.49 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy iSERA Lifesciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for iSERA Lifesciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of iSERA Lifesciences shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio iSERA Lifesciences shares is 0. Useful to assess the stock's value relative to its book value.
To assess iSERA Lifesciences’s valuation compare Sector P/E, P/B which are 142.67 & 3.08 with sector averages, along with growth rates and financial metrics.
The Market Cap of iSERA Lifesciences is 65.16 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of iSERA Lifesciences share price is 77.49 & 1.50. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
iSERA Lifesciences belongs to the Software and IT Services sector.
